{"task_id": "24760f73286eb08c", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 864/905)", "text": " tness-to-drive-a-guide-for-medical-\nprofessionals\n\n--- Page 870 ---\n856\nReferences\nChapter 4: Chest medicine\n1 Johnson DC. Importance of adjusting carbon monoxide diff using capacity (DLCO) and carbon monoxide \ntransfer coeffi  cient (KCO) for alveolar volume. Respir Med 2000; 94(1):28\u201337. http://www.resmedjournal.\ncom/article/S0954-6111(99)90740-0/abstract\n2 Spira A. Airway gene expression; a novel diagnostic test for lung cancer in smokers. Proc Amer Assoc \nCancer Res 2006; 47:242\n3 Doerschuk C. Pulmonary alveolar proteinosis \u2013 is host defense awry? N Engl J Med 2007; 356: 547\u20139. \nhttp://www.nejm.org/doi/full/10.1056/NEJMp068259\n4 NICE. Pneumonia in adults: Diagnosis and management [CG191]. 2014. https://www.nice.org.uk/guid-\nance/cg191\n5 Man SY, Lee N, Ip M, et al. Prospective comparison of three predictive rules for assessing severity of \ncommunity-acquired pneumonia in Hong Kong. Thorax 2007 62:348\u201353. https://www.ncbi.nlm.nih.gov/pmc/\narticles/PMC2092476/\n6 Lim WS. Severity assessment in community-acquired pneumonia: moving on. Thorax 2007; 62:287\u20138. \nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092475/\n7 Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status \nof diagnostic methods. Clin Infect Dis 2007; 44(4):568\u201376. http://cid.oxfordjournals.org/content/44/4/568.\nlong\n8 Stringer JR, Beard CB, Miller RF, et al. A new name for Pneumocystis from humans and new perspectives \non the host-pathogen relationship. Emerg Infect Dis 2002; 8(9):891\u20136.\n9 Kaplan JE, Benson C, Holmes KT, et al. Guidelines for prevention and treatment of opportunistic in-\nfections in HIV-infected adults and adolescents. Atlanta, GA: CDC, 2009. http://www.cdc.gov/mmwr/\npreview/mmwrhtml/rr5804a1.htm\n10 Hui DS. Review of clinical symptoms and spectrum in humans with in\ufb02 uenza A/H5N1 infection. Respirol-\nogy 2008; 13 Suppl 1:S10\u20133. http://www.ncbi.nlm.nih.gov/pubmed/18366521 \n11 The Writing Committee of the World Health Organization (WHO) Consultation on Human In\ufb02 uenza A/\nH5. Avian In\ufb02 uenza A (H5N1) Infection in Humans. N Engl J Med 2005; 353:1374\u201385. http://content.nejm.org/\ncgi/content/full/353/13/1374\n12 Engin A. In\ufb02 uenza type A (H5N1) virus infection. Mikrobiyol Bul 2007; 41(3):485\u201394. http://www.ncbi.\nnlm.nih.gov/pubmed/17933264 \n13 Public Health England. Avian in\ufb02 uenza: guidance and algorithms for managing human cases. 2014. \nhttps://www.gov.uk/government/publications/avian-in\ufb02 uenza-guidance-and-algorithms-for-managing-\nhuman-cases\n14 Avian in\ufb02 uenza guidance and algorithms. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/\nHPAweb_C/1195733851442\n15 British Thoracic Society. Guidelines on severe acute respiratory syndrome. 2004. http://www.brit-\nthoracic.org.uk/guidelines/severe-acute-respiratory-syndrome-guideline.aspx\n16 Hui DS. An overview on severe acute respiratory syndrome (SARS). Monaldi Arch Chest Dis 2005; \n63(3):149\u201357\n17 Gumel AB, Nu\u00f1o M, Chowell G. Mathematical assessment of Canada\u2019s pandemic in\ufb02 uenza prepared-\nness plan. Can J Infect Dis Med Microbiol 2008; 19(2):185\u201392. https://www.ncbi.nlm.nih.gov/pmc/articles/\nPMC2605860/\n18 Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax \n2010; 65 Suppl 1:i1\u201358. http://thorax.bmj.com/content/65/Suppl_1/i1.long\n19 Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic \ufb01 brosis and \nthe G551D mutation. N Engl J Med 2011; 365(18):1663\u201372. https://www.ncbi.nlm.nih.gov/pmc/articles/\nPMC3230303/\n20 Rehman A, Baloch NU, Janahi IA. Lumacaftor\u2013ivacaftor in patients with cystic \ufb01 brosis homozygous for \nPhe508del CFTR. N Engl J Med 2015; 373(18):1783\u20134. http://www.nejm.org/doi/pdf/10.1056/NEJMc1510466\n21 Alton EW, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in \npatients with cystic \ufb01 brosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir \nMed 2015; 3(9):684\u201391. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673100/\n22 NICE. Guidance on the diagnosis and treatment of lung cancer. 2011. http://guidance.nice.org.uk/\nCG121\n23 Bertazzi PA. Descriptive epidemiology of malignant mesothelioma. Med Lav 2005; 96(4):287\u2013303. http://\nwww.ncbi.nlm.nih.gov/pubmed/16457426\n24 Tsiouris A, Walesby RK. Malignant pleural mesothelioma: current concepts in treatment. Nat Clin Pract \nOncol 2007; 4(6):344\u201352. http://www.nature.com/nrclinonc/journal/v4/n6/full/ncponc0839.html\n25 NICE. Lung cancer: Diagnosis and management [CG121]. 2011. http://guidance.nice.org.uk/CG121\n26 Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135:805\u201326. http://www.sciencedirect.\ncom/science/article/pii/S0012369209602099\n27 Graf K. Five-years surveillance of invasive aspergillosis in a university hospital. BMC Infect Dis 2011; \n11:163. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128051/\n28 Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary ther-\napy of invasive aspergillosis. N Engl J Med 2002; 347:408\u201315. http://www.nejm.org/doi/full/10.1056/NEJ-\nMoa020191\n29 Morf\u00edn-Maciel B, Barrag\u00e1n-Meijueiro Mde L, Nava-Ocampo AA. Individual and family household smok-\ning habits as risk factors for wheezing among adolescents. Prev Med 2006; 43(2):98\u2013100. http://www.scien-\ncedirect.com/science/article/pii/S0091743506001538\n30 St\u00f8rdal K, Johannesdottir GB, Bentsen BS, et al. Acid suppression does not change respiratory symp-\ntoms in children with asthma and gastro-oesophageal re\ufb02 ux disease. Arch Dis Child 2005; 90(9):956\u201360. \nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720585/\n31 Douglas JD. If you want to cure their asthma, ask about their job. Prim Care Respir J 2005; 14(2):65\u201371. \nhttp://www.nature.com/articles/pcrj2004122\n32 Holloway EA, West RJ. Integrated breathing and relaxation training (the Papworth Method) for adults \nwith asthma in primary care: a randomised controlled trial. Thorax 2007; 62(12):1039\u201342. https://www.ncbi.\nnlm.nih.gov/pmc/articles/PMC2094294/", "text_length": 6003, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 864/905)", "type": "chunk", "chunk_index": 863, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.674459", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.675286", "status": "complete", "chunks_added": 4}